tiprankstipranks
Advertisement
Advertisement

AnteoTech advances battery and diagnostics commercialisation with new validations and CLIA partnership

Story Highlights
  • AnteoTech advanced its battery portfolio with independent validations, new SiMRAX sampling, and progressing Ultranode 95 drone-focused partnerships.
  • The company expanded its life sciences footprint via a major CLIA collaboration, stronger Serum Institute demand, and new market entry and distribution initiatives.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
AnteoTech advances battery and diagnostics commercialisation with new validations and CLIA partnership

Claim 55% Off TipRanks

AnteoTech Ltd ( (AU:ADO) ) just unveiled an update.

AnteoTech reported a March 2026 quarter centred on commercial execution, with record product sample dispatches, expanded participation in global industry forums and steady progress in converting its enlarged sales pipeline. In Advanced Battery Technologies, Ultranode 70 and Ultranode 95 received independent validation in coin cell and pouch formats, SiMRAX customer sampling commenced under a U.S. joint development and sales agreement, and negotiations advanced on two non-exclusive Ultranode 95 development deals with drone-focused battery makers, supporting a growing pipeline of 129 leads and multiple active evaluations.

The Life Sciences business launched a new collaborative CLIA product development program with a major global life sciences company targeting the US$13 billion CLIA market, released performance data showing AnteoBind NXT magnetic particles outperform Tosyl-based competitors, and continued to build recurring revenue under its five-year take-or-pay contract with Serum Institute of India. Market expansion activities included attendance at key conferences in India and the U.S., pursuit of new distribution in Japan and India, and ongoing engagement with emerging diagnostic platform partners, positioning AnteoTech to translate its technology gains into broader commercial adoption across both core segments.

More about AnteoTech Ltd

AnteoTech Ltd is an Australian supplier of advanced material solutions serving the lithium-ion battery and life sciences diagnostics markets. Its Advanced Battery Technologies arm develops high-performance silicon anode additives such as Ultranode and SiMRAX for applications including drones, while its Life Sciences division provides surface chemistry products like AnteoBind for CLIA and ELISA assays to global diagnostic manufacturers.

Average Trading Volume: 3,155,524

Technical Sentiment Signal: Sell

Current Market Cap: A$35.68M

Find detailed analytics on ADO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1